Financial and counseling support for transgender women to improve health services access
Official title: Economic Navigation and Strengthening to Research Unrestricted Services for Transgender Women (ENTRUST)
Run by University of Central Florida · NCT06202898 · Data updated 2026-11-12
This study tests whether financial help and personalized counseling can make it easier for transgender women to access substance use services and HIV prevention methods like PrEP.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | Men only |
| Enrollment | 110 (estimated) |
| Sponsor | University of Central Florida Academic / other |
| Locations | 1 site (Orlando, Florida) |
| Status | Recruiting |
| Started | July 11, 2023 |
| Main results expected | November 2025 |
| Study ends | June 2027 |
| Registry record updated | December 6, 2024 |
| Trial ID | NCT06202898 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are transgender women aged 18 and older who are not consistently using PrEP and can communicate in English or Spanish.
✕Probably not a fit
Patients with life-threatening substance use disorders or those unable to adhere to study procedures may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study aims to explore how financial stabilization and tailored counseling can enhance the likelihood of transgender women accessing substance use services and pre-exposure prophylaxis (PrEP) if they are HIV-negative. It addresses the critical gap in understanding the relationship between substance use disorders and adherence to antiretroviral treatment (ART) among transgender women. By focusing on this vulnerable population, the study seeks to improve engagement in HIV prevention initiatives and treatment adherence, ultimately contributing to better health outcomes.
Why it matters
Potential benefit: If successful, this approach could significantly improve health service access and treatment adherence for transgender women, reducing HIV transmission rates.
How similar studies have gone: While there is limited literature specifically addressing this approach, similar studies have shown promise in improving health outcomes for marginalized populations.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Aged ≥18 years * Male at birth * Identify as a woman/transgender woman * Should not be consistently using PrEP (less than four doses per week) * Should not have any known allergy or adverse reaction to PrEP or the active drug tenofovir in ART. One of the goals of the study is to move more people into a PrEP program * Be able to speak and understand spoken English and/or Spanish (including persons who cannot read or write) * Have a smart phone that can take pictures Exclusion Criteria: * Unwilling to adhere to study procedures * Participation in an HIV vaccine trial * Have a life-threatening SUD\* * Any condition, that in the opinion of the study staff, would make participation in the study unsafe, or interfere with achieving the study objective such as medical conditions which prevents the use of PrEP * Unable to provide consent
Where it's running
-
University of Central Florida
Orlando, Florida, United States Recruiting
Study contacts
- Principal investigator: Elena Cyrus, PhD — University of Central Florida
- Study coordinator: Elena Cyrus, PhD
- Email: elena.cyrus@ucf.edu
- Phone: 4072661507
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Expanding access to depression treatment for adults with HIV to improve mood and viral control.
This project tests whether giving HIV clinics extra training and support helps more adults with HIV and depression start proven depression treatments and reach viral suppression within a year.
-
Collaborative care program for young Black and Latino men at risk for HIV
This study tests a new support program to help young Black and Latino men at risk for HIV start taking prevention medication and manage their substance use better.
-
Creating a city-wide cohort of HIV-infected individuals in Washington, DC
This study is creating a big database of people living with HIV in Washington, DC, to help improve their care and health outcomes by collecting and sharing important information from different clinics.
-
Project SHIELD 2.0: Police Education to Support Public Health in Kentucky
Aimed at police in Kentucky, this program tests whether SHIELD training given to officers, with health workers helping deliver it, can reduce drug-related arrests and steer people who use drugs toward MOUD and other health services.
-
New ways to diagnose lymphoma and multicentric Castleman disease in people living with HIV
This study tests a quick, point-of-care nucleic acid test to help diagnose lymphoma and multicentric Castleman disease in people living with HIV in sub-Saharan Africa.
-
Bridge to Belonging: A Peer‑Led Program to Reduce Loneliness and Depression in older gay and bisexual men with HIV
This program tests a peer-delivered, manualized approach to help men aged 50+ with HIV connect to LGBTQ+-affirming elder services to see if it reduces loneliness and depressive symptoms.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.